NASDAQ · Biotechnology

Ocugen Inc (OCGN)

$1.02 -0.49%

Add alert

27 Oversold Daily RSI (14) · 11 Sep 2026

Moving averages

SMA 200$1.51-32.45%

Company profile

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the development of gene therapies to cure diseases of blindness. The company is headquartered in Malvern, Pennsylvania.

SectorHealthcare

IndustryBiotechnology

Market cap$345.89M

P/E ratioNone

EPS$-0.26

Beta2.208

Dividend yield0.00%

52-week high$2.73

52-week low$1.01

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 44 VRTX Vertex Pharmaceuticals Inc RSI 44 CRSP CRISPR Therapeutics AG RSI 39 IOVA Iovance Biotherapeutics Inc RSI 63 RXRX Recursion Pharmaceuticals Inc - Class A RSI 46 MRNA Moderna Inc RSI 61 VKTX Viking Therapeutics Inc RSI 42 SRPT Sarepta Therapeutics Inc RSI 53 EDIT Editas Medicine Inc RSI 41 NVAX Novavax Inc RSI 54

Free forever

RSI alerts for OCGN

Get an email the moment Ocugen Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 13 September 2026 at 1:24 PM EDT